Immunohistochemical Analysis for hMLH1 and hMSH2 Expression in Colorectal Cancer

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Defective DNA mismatch repair (MMR) is implicated in a significant proportion of colorectal cancers (CRC).
• In hereditary non-polyposis colorectal cancer (HNPCC), MMR deficiency typically arises from mutations in the hMLH1 and hMSH2 genes.
• Sporadic CRC with MMR defects often results from hypermethylation of the hMLH1 promoter.

Purpose of the Study:

• To elucidate the mechanisms underlying defective DNA mismatch repair in colorectal cancer.
• To understand the genetic and epigenetic alterations associated with MMR deficiency in both hereditary and sporadic CRC.
• To highlight the link between MMR defects and microsatellite instability.

Main Methods:

• Analysis of DNA mismatch repair gene status (hMLH1, hMSH2) in colorectal tumors.
• Investigation of gene mutations and promoter methylation patterns.
• Assessment of microsatellite instability (MSI) phenotype in tumors.

Main Results:

• Inactivating mutations in hMLH1 or hMSH2 lead to loss of protein expression.
• hMLH1 promoter hypermethylation results in reduced hMLH1 expression.
• Defective MMR is strongly associated with the microsatellite instability-high (MSI-H) phenotype.

Conclusions:

• Defective DNA mismatch repair is a key feature in a substantial subset of colorectal cancers.
• Distinct molecular mechanisms (mutations vs. hypermethylation) underlie MMR deficiency in HNPCC and sporadic CRC.
• Microsatellite instability serves as a reliable indicator of defective DNA mismatch repair in colorectal tumors.